Pharmaceuticals
-
HEALTH
RFK Jr. is gutting minority health offices across HHS that are key to reducing health disparities
Employees of the Department of Health and Human Services (HHS) stand outside the Mary E. Switzer Memorial Building, after it…
Read More » -
Business
Where the ‘Fast Money’ traders see the most promise — and problems — over President Trump’s next 100 days
To get more personalized investment strategies, join us for our next “Fast Money” Live event on Thursday, June 5, at…
Read More » -
HEALTH
Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D
Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in New York…
Read More » -
HEALTH
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 30%
The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available…
Read More » -
HEALTH
Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall
The Pfizer logo is seen outside the pharmaceutical company’s manufacturing plant, in Newbridge, Ireland February 10, 2025. Clodagh Kilcoyne |…
Read More » -
HEALTH
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
Read More » -
HEALTH
Why we’re lowering our Bristol Myers price target despite an earnings beat, guidance raise
Bristol Myers Squibb ‘s earnings beat and rosy outlook Thursday did not resolve lingering issues for the stock. But it…
Read More » -
HEALTH
Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs
FILE PHOTO: The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023.…
Read More » -
HEALTH
Merck lowers profit outlook, partly due to $200 million expected tariff hit
Nurphoto | Nurphoto | Getty Images Merck on Thursday lowered its full-year profit guidance, citing $200 million in estimated costs…
Read More » -
HEALTH
FDA to phase out dyes used in Flamin’ Hot Cheetos, Skittles and other snacks
Candy is displayed for sale, as U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., along with FDA…
Read More »